A5038620803- Public Health in Brazil
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Supply Chain Resilience and Risk Management
- Pharmaceutical Practices and Patient Outcomes
- Health, Nursing, Elderly Care
- Academic Research in Diverse Fields
- Brazilian Legal Issues
Fundação Oswaldo Cruz
2017-2022
Faculdades Oswaldo Cruz
2022
Escola Nacional de Saúde Pública
2017
This article examines pharmaceutical services and access to essential medicines in Brazil during the 30 years since advent of Brazil's Unified Health System from a comprehensiveness perspective. The following topics are addressed: "realignment" services; human resources concept; rational use medicines; technological advances drug manufacturing; ethical regulation. With strong regulatory focus structural framework centered on National Medicines Policy, past three decades represent mixture...
Pharmaceutical services and the formulation of a medicines policy are SUS areas ensured by organic health care law 8,080/90. Thus, after widely participative process, involving stakeholders, National Medicines Policy (NMP) was approved in 1998 Ordinance 3,916.The NMP presents directives priorities, aligned with law, which should guide federal, states municipals entities actions to achieve goals. Considering almost 20 years NMP, this paper took stock discussed some light principles. It not...
The health crisis triggered by the COVID-19 pandemic has challenged public management in several countries to ensure timely and efficient procurement of various technologies necessary cope with it, such as medicines, diagnostic tests, personal protective equipment (PPE) medical materials/equipment, among others. This article introduces a protocol for scoping review that aims map synthesize studies portraying capacity related inputs used coping arising from COVID-19. is intended document...